JYP0061

· Guangzhou JOYO Pharma Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JYP0061, covering 2024-11-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]